Erratum: Embelin-induced brain glioma cell apoptosis and cell cycle arrest via the mitochondrial pathway (Oncology Reports (2013) 29 (2473-2478) DOI: 10.3892/or.2013.2369);Embelin-induced brain glioma cell apoptosis and cell cycle arrest via the mitochondrial pathway

Oncology Reports

Volumn 29, Issue 6, 2013, Pages 2473-2478

  Wang, Aiping ^a   Zhang, Baochao ^a   Zhang, Jiandang ^a   Wu, Wei ^b,c  

^a Central Hospital of Nanyang City   (China)

^b JILIN UNIVERSITY   (China)

^c WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Cell apoptosis; Embelin; Glioma; Mitochondria; XIAP

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; CASPASE; CASPASE 3; CASPASE 8; CASPASE 9; CYTOCHROME C; EMBELIN; PROTEIN BAK; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL;

APOPTOSIS; ARTICLE; CANCER CELL; CELL CYCLE; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL PROLIFERATION; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVITY; FLOW CYTOMETRY; GLIOMA; HUMAN; HUMAN CELL; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

EID: 84876276584     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2023.8691     Document Type: Erratum

References (33)

1. Ricard D, Idbaih A, Ducray F, Lahutte M, Hoang-Xuan K and Delattre JY: Primary brain tumours in adults. Lancet 379: 1984-1996, 2012.
2. Johannesen TB, Langmark F and Lote K: Cause of death and long-term survival in patients with neuro-epithelial brain tumours: a population-based study. Eur J Cancer 39: 2355-2363, 2003. (Pubitemid 37214860)
3. Yeo CW, Ng FS, Chai C, Tan JM, Koh GR, Chong YK, Koh LW, Foong CS, Sandanaraj E, Holbrook JD, Ang BT, Takahashi R, Tang C and Lim KL: Parkin pathway activation mitigates glioma cell proliferation and predicts patient survival. Cancer Res 72: 2543-2553, 2012.
4. Zhang Y, Chao T, Li R, Liu W, Chen Y, Yan X, Gong Y, Yin B, Liu W, Qiang B, Zhao J, Yuan J and Peng X: MicroRNA-128 inhibits glioma cells proliferation by targeting transcription factor E2F3a. J Mol Med 87: 43-51, 2009.
5. Komotar RJ, Otten ML, Moise G and Connolly ES Jr: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma - a critical review. Clin Med Oncol 2: 421-422, 2008.
6. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E and Mirimanoff RO: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352: 987-996, 2005. (Pubitemid 40349501)
7. Uren AG, Pakusch M, Hawkins CJ, Puls KL and Vaux DL: Cloning and expression of apoptosis inhibitory protein homologs that function to inhibit apoptosis and/or bind tumor necrosis factor receptor-associated factors. Proc Natl Acad Sci USA 93: 4974-4978, 1996.
8. Takahashi R, Deveraux Q, Tamm I, Welsh K, Assa -Munt N, Salvesen GS and Reed JC: A single BIR domain of XIAP sufficient for inhibiting caspases. J Biol Chem 273: 7787-7790, 1998. (Pubitemid 28168819)
9. Reuter S, Prasad S, Phromnoi K, Kannappan R, Yadav VR and Aggarwal BB: Embelin suppresses osteoclastogenesis induced by receptor activator of NF-κB ligand and tumor cells in vitro through inhibition of the NF-κB cell signaling pathway. Mol Cancer Res 8: 1425-1436, 2010.
10. Nikolovska-Coleska Z, Xu L, Hu Z, Tomita Y, Li P, Roller PP, Wang R, Fang X, Guo R, Zhang M, Lippman ME, Yang D and Wang S: Discovery of embelin as a cell-permeable, small-molecular weight inhibitor of XIAP through structure-based computational screening of a traditional herbal medicine three-dimensional structure database. J Med Chem 47: 2430-2440, 2004. (Pubitemid 38580082)
11. Kim SW, Kim SM, Bae H, Nam D, Lee JH, Lee SG, Shim BS, Kim SH, Ahn KS, Choi SH, Sethi G and Ahn KS: Embelin inhibits growth and induces apoptosis through the suppression of Akt/mTOR/S6K1 signaling cascades. Prostate 73: 296-305, 2013.
12. Danquah M, Li F, Duke CB III, Miller DD and Mahato RI: Micellar delivery of bicalutamide and embelin for treating prostate cancer. Pharm Res 26: 2081-2092, 2009.
13. Mori T, Doi R, Kida A, Nagai K, Kami K, Ito D, Toyoda E, Kawaguchi Y and Uemoto S: Effect of the XIAP inhibitor Embelin on TRAIL-induced apoptosis of pancreatic cancer cells. J Surg Res 142: 281-286, 2007. (Pubitemid 47418828)
14. Aird KM, Ding X, Baras A, Wei J, Morse MA, Clay T, Lyerly HK and Devi GR: Trastuzumab signaling in ErbB2- overexpressing inflammatory breast cancer correlates with X-linked inhibitor of apoptosis protein expression. Mol Cancer Ther 7: 38-47, 2008.
15. Dai Y, Qiao L, Chan KW, Yang M, Ye J, Ma J, Zou B, Gu Q, Wang J, Pang R, Lan HY and Wong BC: Peroxisome proliferator-activated receptor-gamma contributes to the inhibitory effects of Embelin on colon carcinogenesis. Cancer Res 69: 4776-4783, 2009.
16. Zhong J, Kong X, Zhang H, Yu C, Xu Y, Kang J, Yu H, Yi H, Yang X and Sun L: Inhibition of CLIC4 enhances autophagy and triggers mitochondrial and ER stress-induced apoptosis in human glioma U251 cells under starvation. PLoS One 7: e39378, 2012.
17. Zhou J, Cheng G, Cheng G, Tang HF and Zhang X: Novaeguinoside II inhibits cell proliferation and induces apoptosis of human brain glioblastoma U87MG cells through the mitochondrial pathway. Brain Res 1372: 22-28, 2011.
18. Ordys BB, Launay S, Deighton RF, McCulloch J and Whittle IR: The role of mitochondria in glioma pathophysiology. Mol Neurobiol 42: 64-75, 2010.
19. Du J, Tang B, Wang J, Sui H, Jin X, Wang L and Wang Z: Antiproliferative effect of alpinetin in BxPC-3 pancreatic cancer cells. Int J Mol Med 29: 607-612, 2012.
20. Zhang ZF, Guo Y, Zhang JB and Wei XH: Induction of apoptosis by chelerythrine chloride through mitochondrial pathway and Bcl-2 family proteins in human hepatoma SMMC-7721 cell. Arch Pharm Res 34: 791-800, 2011.
21. Tang B, Zhang Y, Liang R, Yuan P, Du J, Wang H and Wang L: Activation of the δ-opioid receptor inhibits serum deprivation-induced apoptosis of human liver cells via the activation of PKC and the mitochondrial pathway. Int J Mol Med 28: 1077-1085, 2011.
22. Kerr JF, Wyllie AH and Currie AR: Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26: 239-257, 1972.
23. Chiarugi P and Giannoni E: Anoikis: a necessary death program for anchorage-dependent cells. Biochem Pharmacol 76: 1352-1364, 2008.
24. Heo JY, Kim HJ, Kim SM, Park KR, Park SY, Kim SW, Nam D, Jang HJ, Lee SG, Ahn KS, Kim SH, Shim BS, Choi SH and Ahn KS: Embelin suppresses STAT3 signaling, proliferation, and survival of multiple myeloma via the protein tyrosine phos phatase PTEN. Cancer Lett 308: 71-80, 2011.
25. Hu R, Zhu K, Li Y, Yao K, Zhang R, Wang H, Yang W and Liu Z: Embelin induces apoptosis through down-regulation of XIAP in human leukemia cells. Med Oncol 28: 1584-1588, 2011.
26. Allensworth JL, Aird KM, Aldrich AJ, Batinic-Haberle I and Devi GR: XIAP inhibition and generation of reactive oxygen species enhances TRAIL sensitivity in inflammatory breast cancer cells. Mol Cancer Ther 11: 1518-1527, 2012.
27. Joy B, Sivadasan R, Abraham TE, John M, Sobhan PK, Seervi M and TRS: Lysosomal destabilization and cathepsin B contributes for cytochrome c release and caspase activation in embelin-induced apoptosis. Mol Carcinog 49: 324-336, 2010.
28. Von Haefen C, Wendt J, Semini G, Sifringer M, Belka C, Radetzki S, Reutter W, Daniel PT and Danker K: Synthetic glycosidated phospholipids induce apoptosis through activation of FADD, caspase-8 and the mitochondrial death pathway. Apoptosis 16: 636-651, 2011.
29. Burlacu A: Regulation of apoptosis by Bcl-2 family proteins. J Cell Mol Med 7: 249-257, 2003.
30. Saito M, Korsmeyer SJ and Schlesinger PH: BAX-dependent transport of cytochrome c reconstituted in pure liposomes. Nat Cell Biol 2: 553-555, 2000.
31. Matsuyama S, Llopis J, Deveraux QL, Tsien RY and Reed JC: Changes in intramitochondrial and cytosolic pH: early events that modulate caspase activation during apoptosis. Nat Cell Biol 2: 318-325, 2000.
32. Fiandalo MV and Kyprianou N: Caspase control: protagonists of cancer cell apoptosis. Exp Oncol 34: 165-175, 2012.
33. Wen X, Lin ZQ, Liu B and Wei YQ: Caspase -mediated programmed cell death pathways as potential therapeutic targets in cancer. Cell Prolif 45: 217-224, 2012.